Toggle Main Menu Toggle Search

Open Access padlockePrints

Chest wall perforator flaps for partial breast reconstruction: An observational cohort study of 290 women to evaluate clinical and oncological outcomes

Lookup NU author(s): Angus Reid, Dr ISABEL BURRIDGE, Loraine Kalra, Rob Thomas, Joe O'Donoghue, Dr Guy TaylorORCiD, Henry Cain

Downloads


Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).


Abstract

© 2025 The AuthorsBackground: Partial breast reconstruction (PBR) using chest wall perforator flaps (CWPFs) is an oncoplastic technique utilised to facilitate breast conservation surgery (BCS). It is particularly applicable in women with a larger tumour-to-breast volume ratio requiring volume replacement rather than volume displacement. This single-centre retrospective cohort study aimed to explore the safety and efficacy of PBR using CWPFs. Method: All patients who underwent PBR using a CWPF following wide local excision between March 2016 and August 2024 were reviewed. Data was extracted from hospital electronic patient records and statistical analysis performed using R-Studio® (alpha = 0.05). Results: Of 290 cases identified: 237 had invasive cancers and 53 ductal carcinoma in situ (DCIS). The median age at presentation was 59 years and the median tumour size 22 mm, with multifocal tumours in 22.1 % of cases and extensive DCIS in 27.0 % of invasive cancers. Overall, complication rates were low (n = 83, 28.6 %) with 6.9 % of patients requiring a return to theatre. Margins were involved in 17.8 %, with 15.6 % requiring re-excision. The locoregional recurrence (LRR) rate was 2.9 % and disease-free survival (DFS) 93.8 % with a median follow-up of 3.1 years (n = 276). A subset analysis of women receiving surgery before January 2020 (n = 96) with a follow-up of 5.1 years had a LRR of 4.2 %. Conclusion: This study reports acceptable rates of complications, margin re-excision and LRR, demonstrating the safety and efficacy of utilising PBR with CWPFs for the treatment of breast cancer. CWPFs offer the opportunity to extend the boundaries of BCS to those women who may otherwise require a mastectomy.


Publication metadata

Author(s): Reid A, Sibbering L, Burridge I, Kalra L, Critchley A, Thomas R, Pieri A, Carter J, O'Donoghue JM, Taylor G, Fairhurst K, Cain H

Publication type: Article

Publication status: Published

Journal: European Journal of Surgical Oncology

Year: 2025

Volume: 51

Issue: 11

Print publication date: 01/11/2025

Online publication date: 02/09/2025

Acceptance date: 02/09/2025

Date deposited: 30/09/2025

ISSN (print): 0748-7983

ISSN (electronic): 1532-2157

Publisher: W.B. Saunders Ltd

URL: https://doi.org/10.1016/j.ejso.2025.110430

DOI: 10.1016/j.ejso.2025.110430

Data Access Statement: The dataset was accessed through the Newcastle Upon Tyne Hospitals Trust electronic patient records. This is not publicly available at present as not all patients have consented for data to be shared and it contains confidential information such as patient identifiers.

PubMed id: 40939446


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Susan Channon Breast Cancer Trust

Share